Sysmex

Skip Navigation

SearchMenu

About Sysmex

Press Releases

Management & Business Management & Business
Jan. 13, 2016

Medicaroid Corporation’s US Subsidiary Commences Operations in Silicon Valley

  Medicaroid Corporation (HQ: Kobe, Japan; President: Yasuhiko Hashimoto; hereinafter, "Medicaroid"), a joint venture between Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu; hereinafter, "Sysmex") and Kawasaki Heavy Industries, Ltd. (HQ: Kobe, Japan; President: Shigeru Murayama; hereinafter, "Kawasaki"), has established a subsidiary in the United States, MEDICAROID, INC., which commenced operations in January 2016. MEDICAROID, INC. will cooperate with Medicaroid to conduct medical robot technology development, marketing activities and regulatory affairs for approval by the US Food and Drug Administration (FDA), with the aim of expanding business going forward.

  The scope of application for robotic assisted surgery, which was first introduced in the 1990s in the United States, is expanding rapidly as a type of minimum-invasive therapy, as various instances of clinical research and studies have shown evidence of its safety and efficacy. In Japan, medical robots were approved as authorized medical devices in 2009 and have begun to be applied in surgical therapy for prostate cancer and other diseases.

  The United States is the world’s largest market for medical robots, accounting for more than half of the total. The region around the Bay Area of San Jose, known as Silicon Valley, is a leading area for medical robot technology, being home to distinguished IT companies, universities, medical institutes and medical robot companies.

  Through MEDICAROID, INC’s operation in this leading-edge environment, Medicaroid will develop the US market for made-in-Japan medical robots utilizing the R&D and manufacturing capabilities of Sysmex and Kawasaki, thereby contributing to the advancement of medicine.
Outline of the MEDICAROID, INC.
  Location: San Jose, CA, USA
  President: Yasuhiro Kochi
  Establishment: October 9, 2015
  Capital: US$1,500,000 (wholly supplied by Medicaroid Corporation)
Note: Medicaroid Corporation is an equal joint venture between Sysmex and Kawasaki.
  Employees: Eight
  Line of business: Technology development, regulatory affairs, marketing activities, sales and service for medical robots

Related link
  Medicaroid Corporation http://www.medicaroid.com/en/

*Information contained in the press release is current as of the date of the announcement,
but may be subject to change without prior notice.

Back to "Press Releases"